Biggest News Aggregation in the World
📰 Reduction Oxidation Potential News

Reduction Oxidation Potential News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Reduction Oxidation Potential. Real-time updates on events, politics, business and more.

Relief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated Trial of Nexo

Relief Therapeutics Holding SA / Key word(s): Study22-Sep-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated Trial of Nexodyn for Epid...
Northwestern University United States Amy Paller Michael Miller Nermeen Varawalla Ann Roberth Lurie

Relief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated Trial of Nexodyn for Epidermolysis Bullosa at Ann & Robert H. Lurie Children's Hospital of Chicago

Relief Therapeutics Holding SA / Key word(s): Study Relief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated Trial of Nexodyn for Epidermolysis Bullosa at Ann & Robert H. Lurie Childrens Hospital of Chicago 22-Sep-2022 / 07:00 CET/CEST Release of an ad hoc anno...
Switzerland General Northwestern University United States Amy Paller Michael Miller Nermeen Varawalla

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated Trial of Nexodyn for Epidermolysis Bullosa at Ann & Robert H. Lurie Children's Hospital of Chicago

Relief Therapeutics Holding SA / Key word(s): Study Relief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated Trial of Nexodyn for Epidermolysis Bullosa at Ann & Robert
Switzerland General Northwestern University United States Amy Paller Michael Miller Nermeen Varawalla

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief Therapeutics Reports Two Publications of Positive Data on Nexodyn(R) AOS for Hard-to-Heal Ulcers

EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Scientific publication Relief Therapeutics Reports Two Publications of Positive Data on Nexodyn(R) AOS for Hard-to-Heal Ulcers 20-Oct-2021
Elia Ricci Michael Miller Jack Weinstein Advita Lifescience Gmb Pharma Research Eqs Group

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Relief's Subsidiary, APR Applied Pharma Research, Reports Data Published in Journal of Wound Care, Indicating Nexodyn(R) AOS Highly Effective Treatment to Support Healing of Hard-to-Heal Leg Ulcers

EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Scientific publication Relief's Subsidiary, APR Applied Pharma Research, Reports Data Published in Journal of Wound Care, Indicating
Michael Miller Jack Weinstein Advita Lifescience Gmb Robert Strohal Pharma Research Eqs Group

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science